Effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease
<p><strong>BACKGROUND:</strong> Chronic kidney disease (CKD) is associated with fluid excess which can be estimated by bioimpedance spectroscopy. We aimed to assess effects of sodium glucose co-transporter 2 inhibition on bioimpedance-derived “Fluid Overload” and adiposity in a CKD...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Journal article |
Language: | English |
Published: |
American Society of Nephrology
2023
|